Electromagnetic controlled cortical impact device for precise, graded experimental traumatic brain injury.

Genetically modified mice represent useful tools for traumatic brain injury (TBI) research and attractive preclinical models for the development of novel therapeutics. Experimental methods that minimize the number of mice needed may increase the pace of discovery. With this in mind, we developed and characterized a prototype electromagnetic (EM) controlled cortical impact device along with refined surgical and behavioral testing techniques. By varying the depth of impact between 1.0 and 3.0 mm, we found that the EM device was capable of producing a broad range of injury severities. Histologically, 2.0-mm impact depth injuries produced by the EM device were similar to 1.0-mm impact depth injuries produced by a commercially available pneumatic device. Behaviorally, 2.0-, 2.5-, and 3.0-mm impacts impaired hidden platform and probe trial water maze performance, whereas 1.5-mm impacts did not. Rotorod and visible platform water maze deficits were also found following 2.5- and 3.0-mm impacts. No impairment of conditioned fear performance was detected. No differences were found between sexes of mice. Inter-operator reliability was very good. Behaviorally, we found that we could statistically distinguish between injury depths differing by 0.5 mm using 12 mice per group and between injury depths differing by 1.0 mm with 7-8 mice per group. Thus, the EM impactor and refined surgical and behavioral testing techniques may offer a reliable and convenient framework for preclinical TBI research involving mice.

[1]  H. Thompson,et al.  Delayed inhibition of Nogo-A does not alter injury-induced axonal sprouting but enhances recovery of cognitive function following experimental traumatic brain injury in rats , 2005, Neuroscience.

[2]  L. Mucke,et al.  Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein , 1995, Nature.

[3]  J. Trojanowski,et al.  Twofold overexpression of human β‐amyloid precursor proteins in transgenic mice does not affect the neuromotor, cognitive, or neurodegenerative sequelae following experimental brain injury , 1998, The Journal of comparative neurology.

[4]  V. Howard,et al.  Unbiased Stereology: Three-Dimensional Measurement in Microscopy , 1998 .

[5]  T A Gennarelli,et al.  Modification of the cortical impact model to produce axonal injury in the rat cerebral cortex. , 1994, Journal of neurotrauma.

[6]  Jacqueline N. Crawley,et al.  What's Wrong With My Mouse? , 2007 .

[7]  J. Trojanowski,et al.  Vitamin E reduces amyloidosis and improves cognitive function in Tg2576 mice following repetitive concussive brain injury , 2004, Journal of neurochemistry.

[8]  A. Buki,et al.  All roads lead to disconnection? – Traumatic axonal injury revisited , 2006, Acta Neurochirurgica.

[9]  Konrad Sandau,et al.  Unbiased Stereology. Three‐Dimensional Measurement in Microscopy. , 1999 .

[10]  P. Kochanek,et al.  Adenosine A1 Receptor Knockout Mice Develop Lethal Status Epilepticus after Experimental Traumatic Brain Injury , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[11]  D. Graham,et al.  Slow, medium, or fast re-warming following post-traumatic hypothermia therapy? An ultrastructural perspective. , 2005, Journal of neurotrauma.

[12]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[13]  A. Faden,et al.  Sustained sensory/motor and cognitive deficits with neuronal apoptosis following controlled cortical impact brain injury in the mouse. , 1998, Journal of neurotrauma.

[14]  J. Trojanowski,et al.  Brain trauma induces massive hippocampal neuron death linked to a surge in beta-amyloid levels in mice overexpressing mutant amyloid precursor protein. , 1998, The American journal of pathology.

[15]  D. Michaelson,et al.  Susceptibility of transgenic mice expressing human apolipoprotein E to closed head injury: The allele E3 is neuroprotective whereas E4 increases fatalities , 2000, Neuroscience.

[16]  W. Dietrich,et al.  The effect of therapeutic hypothermia on the expression of inflammatory response genes following moderate traumatic brain injury in the rat. , 2005, Brain research. Molecular brain research.

[17]  J. Povlishock,et al.  Administration of the immunophilin ligand FK506 differentially attenuates neurofilament compaction and impaired axonal transport in injured axons following diffuse traumatic brain injury , 2006, Experimental Neurology.

[18]  D. Graham,et al.  Lateral fluid percussion brain injury: a 15-year review and evaluation. , 2005, Journal of neurotrauma.

[19]  S. Korsmeyer,et al.  Traumatic Brain Injury in Mice Deficient in Bid: Effects on Histopathology and Functional Outcome , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[20]  T. Mcintosh,et al.  Experimental models of brain trauma. , 1999, Current opinion in neurology.

[21]  Ronald L. Hayes,et al.  A controlled cortical impact model of traumatic brain injury in the rat , 1991, Journal of Neuroscience Methods.

[22]  E. Hall,et al.  Lack of a gender difference in post-traumatic neurodegeneration in the mouse controlled cortical impact injury model. , 2005, Journal of neurotrauma.

[23]  T. Mcintosh,et al.  Motor and cognitive function evaluation following experimental traumatic brain injury , 2004, Neuroscience & Biobehavioral Reviews.

[24]  P. Kochanek,et al.  Enhanced Oxidative Stress in iNOS-Deficient Mice after Traumatic Brain Injury: Support for a Neuroprotective Role of iNOS , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[25]  Sean M. Grady,et al.  Clinical trials in head injury. , 1999, Journal of neurotrauma.

[26]  G. Murray,et al.  The association between APOE epsilon4, age and outcome after head injury: a prospective cohort study. , 2005, Brain : a journal of neurology.

[27]  D. Holtzman,et al.  Apolipoprotein E4 Influences Amyloid Deposition But Not Cell Loss after Traumatic Brain Injury in a Mouse Model of Alzheimer's Disease , 2002, The Journal of Neuroscience.

[28]  A. Fagan,et al.  Glial Fibrillary Acidic Protein–Apolipoprotein E (apoE) Transgenic Mice: Astrocyte-Specific Expression and Differing Biological Effects of Astrocyte-Secreted apoE3 and apoE4 Lipoproteins , 1998, The Journal of Neuroscience.

[29]  D. Hovda,et al.  Age‐dependent reduction of cortical contusion volume by ketones after traumatic brain injury , 2005, Journal of neuroscience research.

[30]  Rolf Lefering,et al.  Reversal of neuromotor and cognitive dysfunction in an enriched environment combined with multimodal early onset stimulation after traumatic brain injury in rats. , 2005, Journal of neurotrauma.

[31]  E. Hall,et al.  Spatial and temporal characteristics of neurodegeneration after controlled cortical impact in mice: more than a focal brain injury. , 2005, Journal of neurotrauma.

[32]  R. Hayes,et al.  Biomarkers of Proteolytic Damage Following Traumatic Brain Injury , 2004, Brain pathology.

[33]  D. Holtzman,et al.  Morris water maze search strategy analysis in PDAPP mice before and after experimental traumatic brain injury , 2006, Experimental Neurology.

[34]  N. Maeda,et al.  Targeted Replacement of the Mouse Apolipoprotein E Gene with the Common Human APOE3 Allele Enhances Diet-induced Hypercholesterolemia and Atherosclerosis* , 1997, The Journal of Biological Chemistry.

[35]  J. Trojanowski,et al.  Repetitive Mild Brain Trauma Accelerates Aβ Deposition, Lipid Peroxidation, and Cognitive Impairment in a Transgenic Mouse Model of Alzheimer Amyloidosis , 2002, The Journal of Neuroscience.

[36]  A. Fagan,et al.  Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[37]  K. Jellinger Head injury and dementia , 2004, Current opinion in neurology.

[38]  R. Colello,et al.  Enhanced hippocampal neurogenesis by intraventricular S100B infusion is associated with improved cognitive recovery after traumatic brain injury. , 2005, Journal of neurotrauma.

[39]  D F Meaney,et al.  A model of parasagittal controlled cortical impact in the mouse: cognitive and histopathologic effects. , 1995, Journal of neurotrauma.

[40]  J. Gilbert,et al.  Human Apolipoprotein E2, E3, and E4 Isoform-Specific Transgenic Mice: Human-like Pattern of GlialandNeuronal Immunoreactivity in Central Nervous System Not Observed in Wild-Type Mice , 1996, Neurobiology of Disease.

[41]  P. Bayly,et al.  Spatiotemporal evolution of apoptotic neurodegeneration following traumatic injury to the developing rat brain , 2006, Brain Research.

[42]  S. Strittmatter,et al.  Selective temporal and regional alterations of Nogo-A and small proline-rich repeat protein 1A (SPRR1A) but not Nogo-66 receptor (NgR) occur following traumatic brain injury in the rat , 2006, Experimental Neurology.

[43]  S. DeKosky,et al.  Caspase inhibition therapy abolishes brain trauma-induced increases in Aβ peptide: Implications for clinical outcome , 2006, Experimental Neurology.

[44]  H. Thompson,et al.  Experimental models of traumatic brain injury: Do we really need to build a better mousetrap? , 2005, Neuroscience.

[45]  E. Chang,et al.  Heme Oxygenase-2 Protects against Lipid Peroxidation-Mediated Cell Loss and Impaired Motor Recovery after Traumatic Brain Injury , 2003, The Journal of Neuroscience.

[46]  G. Murray,et al.  The association between APOE « 4 , age and outcome after head injury : a prospective cohort study , 2005 .

[47]  J. Trojanowski,et al.  A Review and Rationale for the Use of Genetically Engineered Animals in the Study of Traumatic Brain Injury , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[48]  K A Dunn,et al.  Traumatic brain injury in the United States: A public health perspective. , 1999, The Journal of head trauma rehabilitation.

[49]  A. Faden,et al.  Neuroprotective effects of novel small peptides in vitro and after brain injury , 2005, Neuropharmacology.

[50]  J. Crabbe,et al.  Genetics of mouse behavior: interactions with laboratory environment. , 1999, Science.

[51]  J. W. Lighthall,et al.  Experimental models of brain injury. , 1989, Journal of neurotrauma.

[52]  Jeffrey A. Golden,et al.  Maturation-dependent response of the piglet brain to scaled cortical impact. , 2000, Journal of neurosurgery.

[53]  P. Kochanek,et al.  Promising strategies to minimize secondary brain injury after head trauma , 2003, Critical care medicine.

[54]  E. Shohami,et al.  Long-term effect of HU-211, a novel non-competitive NMDA antagonist, on motor and memory functions after closed head injury in the rat , 1995, Brain Research.

[55]  C. Robertson,et al.  The role of endothelial nitric oxide synthase in the cerebral hemodynamics after controlled cortical impact injury in mice. , 2003, Journal of neurotrauma.

[56]  R. Raghupathi,et al.  Differential behavioral and histopathological responses to graded cortical impact injury in mice. , 2006, Journal of neurotrauma.

[57]  R. Hartman,et al.  Deletion of the n-terminus of murine map2 by gene targeting disrupts hippocampal ca1 neuron architecture and alters contextual memory , 2003, Neuroscience.